Hanall Biopharma한올바이오파마
009420 · KOSPI · ₩009420 · 한올바이오파마
Technical gauge
After the close on Oct 30, 2026Short term
Bearish
1 bullish, 1 neutral, 7 bearish
Medium term
Bearish
0 bullish, 0 neutral, 8 bearish
What the indicators say
Hanall Biopharma closed at 37,500 won, below all of its key moving averages, with the 5-day average at 38,120 won, the 20-day at 41,982.5 won, the 60-day at 49,942.5 won, the 120-day at 51,178.3 won and the 200-day at 51,717.5 won. Momentum is weak across timeframes: RSI(14) is 30, the stochastic %K is 9.7, MACD sits below its signal line, ADX is 27.3 with minus DI at 29 versus plus DI at 11.5, and OBV is trending down. Recent events show breakdowns below support confirmed by MACD and ADX, along with a 50/200-day dead cross, and both the short-term and medium-term gauges read bearish. The nearest resistance cited is 43,500 won, no support level is given, and the Bollinger middle band sits at 41,982.5 won.
Written by AI from the indicator values above. Not advice.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Squeeze! setup
1D timeframeNo squeeze setup on this stock right now.
Chart
2026-10-30O 37,400H 38,350L 36,400C 37,500
Every indicator, chart overlays and the stock's recent technical events, with Pro.Unlock with Pro →
Indicators
- Moving averagesPrice above 0 of 5 averages5d ₩38,120 · 20d ₩41,983 · 60d ₩49,943 · 120d ₩51,178 · 200d ₩51,718Price above its averages is commonly read as an uptrend, below as a downtrend; the 200-day line is widely watched for the long-term trend.
- RSI (14)Oversold (below 30)30.0Measures the speed of recent gains vs losses. Above 70 is often called overbought, below 30 oversold; extremes can last in strong trends.
- MACD (12, 26, 9)Below its signal line-2,862 · signal -2,757 · histogram -105The gap between 12- and 26-day exponential averages. Crossing its signal line is read as momentum turning; above zero, the short-term average is above the long.
- Bollinger Bands (20, 2)Inside the bands₩35,687 – ₩41,983 – ₩48,278 · width 30.0%Bands two standard deviations around the 20-day average. A squeeze (very narrow bands) means unusually quiet trading, which often comes before a bigger move either way.
- Volume vs 20-day averageNormal trading0.66×Trading volume compared with its 20-day average. Moves on heavy volume are usually given more weight.
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProTechnical events, last 90 days
Every indicator, chart overlays and the stock's recent technical events, with Pro.
Unlock with ProShort squeeze tracker
Score hidden
Sign in free to track one stock with the full squeeze tracker.
See the short squeeze score on your watchlist stocks with Pro.Unlock with Pro →or add Squeeze Pro (US$49/month) →
Estimates from short-selling data. Levels are not predictions or trading recommendations.
Share lending and returned shares
Shares lent out (mostly to short sellers), new loans and shares returned each day. A return is either the lender calling the shares back (a recall) or the borrower handing them back, often after buying back a short. The published figures don't say which.
- Shares on loan
- 3.5M
- 6.7% of listed shares
- Loans, 5-day change
- +0.3%
- Loans, 20-day change
- −3.9%
- Returned, last 5 days
- 281.3K
- New loans, last 5 days
- 291.7K
- Short balance vs loans
- 14.7%
- How much of the lent stock is sold short. The higher it is, the more buying back a wave of recalls forces.
Who's borrowing: foreign vs domestic
The shares on loan by who borrowed them and who lent them, by value.
- Foreign share, 5 days
- 0 pts
- Foreign share, 20 days
- —
- Foreign borrowing, 5 days
- −0.5%
As of Oct 29. Domestic borrowers include Korean brokers, some of which borrow for overseas clients, so this shows who holds the loan, not who finally sells short. Not a recommendation.
Unusual return days (last 60 days)
| Day | Returned | Of the loans | Vs usual |
|---|---|---|---|
| Aug 31 | 272.6K | 6.9% | 4.4× |
| Aug 24 | 256.3K | 6.7% | 4.6× |
| Aug 4 | 235.6K | 6.5% | 4.5× |
Unusual = at least 3× the 20-day average, at least 2% of the shares on loan and 10,000 shares.
As of Oct 29. Published figures, one trading day behind. They describe lending, not where the price goes; not a recommendation.
Lending data: Financial Services Commission, Korea (Public Data Portal).
Retail margin & forced selling
Margin loans
₩30T
−7.3% in 5 days · 8th percentile of the last year
Forced selling
₩11B
0.4× the 20-day average
Forced-sale share
1.0%
Unpaid settlements
₩1T
Retail stock borrowing ₩21B
Calm under 30, normal to 50, elevated to 70, high above. From today's forced-sale amount vs its 20-day average, the forced-sale share of receivables, where margin loans sit in their 1-year range, and whether they are being cut fast.
Estimates from public margin-lending statistics. Not a prediction or a recommendation.
Technical indicators describe past price and volume patterns. They are not predictions or recommendations.
Also known as: Hanall Biopharma / 한올바이오파마 / 009420 / KRX:009420
Source: KRX statistical information